Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges

Ruth Jessen Hickman, MD  |  Issue: June 2017  |  June 15, 2017

HIV may increase the risk of certain rheumatic conditions in HIV patients through several mechanisms. Researchers have found the HIV p24 antigen and HIV DNA in the synovial fluid of specific joints affected in individuals with HIV-associated arthropathy.13 Related viruses are known to cause arthritis in animals and humans.4 HIV also causes dysregulation of the immune system that can facilitate autoimmunity.14 The virus causes not only immunodeficiency, but also sometimes other transient serum abnormalities, such as positive IgG rheumatoid factor and anti-CCP antibodies.15

Complexities in Diagnosis

Whether HIV itself is best thought of causing these conditions or simply increasing their likelihood, it can lead to challenges in diagnosis. For example, rheumatoid arthritis can appear quite similar to HIV-associated arthritis, but mistaking one for the other can lead to problems for patients.16

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Adewale O. Adebajo, MBBS, MSc, is a professor of rheumatology and health service research at the University of Sheffield in Sheffield, England. He is also one of the authors of a recent review providing a practical guide for managing inflammatory arthritis in HIV-positive patients.

Dr. Adebajo

Dr. Adebajo

Dr. Adebajo explains, “One of the key issues is that patients who are HIV positive can develop arthritis from HIV that can mimic or disguise rheumatoid arthritis.” He argues for thoughtfulness in giving a diagnosis of rheumatoid arthritis to such HIV-positive patients. “There are various serological indications including ESR and rheumatoid factor and so on, but you need to be cautious in interpreting markers in these patients. I would advocate retesting in those patients at least six months down the line.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Diagnosing these patients incorrectly can have implications for their treatment. “In general, in patients who have HIV-related arthritis, we would initially start with a non-steroidal anti-inflammatory drug and then see how they respond. But we stopped doing that with RA many years ago. Now, once we make a diagnosis of rheumatoid arthritis, we immediately put them on disease-modifying drug, usually methotrexate.”

Monitoring may also be more challenging in patients who have both rheumatoid arthritis and HIV. Dr. Adebajo recommends being aware that such factors as the sedimentation rate are often consistently elevated in patients with HIV, so rheumatologists must use other clinical measures to assess disease status. (Carroll and colleagues recently reviewed more specifics on the management of RA in patients with HIV.)16

HIV-Specific Rheumatic Syndromes

The human immunodeficiency virus in the blood stream.

The human immunodeficiency virus in the blood stream.
Spectral-Design/shutterstock.com

For rheumatologists practicing in the U.S., it is worthwhile being aware of HIV-specific rheumatic syndromes, even though they seem to be occurring less frequently since the availability of cART treatments.

Page: 1 2 3 4 5 6 7 8 9 | Single Page
Share: 

Filed under:ConditionsPractice Support Tagged with:arthralgiascombination antiretroviral therapyDiagnosisdrug interactionHIVMyopathypatient careRheumatic Diseaserheumatologistrheumatologytreament

Related Articles
    HIV Infection: What Rheumatologists Need to Know

    HIV Infection: What Rheumatologists Need to Know

    June 15, 2015

    It has been nearly 35 years since the original descriptions of what now is recognized as AIDS (the acquired immune deficiency syndrome), an advanced form of infection secondary to the human immunodeficiency virus (HIV). The epidemic of HIV infection remains the singular most dramatic epidemic of our generation and will likely remain with us for…

    AFLAR Experts Discuss Highlights, Hurdles in Rheumatology in Africa

    December 18, 2018

    CHICAGO—Rheumatology physicians and researchers from Africa said the field’s resources and medical literature on the continent are slowly expanding, but they repeatedly lamented that the millions who suffer from rheumatic diseases there have major obstacles to overcome to access care. Their reviews and assessments—sometimes grim and sometimes hopeful—came in a session that was a joint…

    APS: What Rheumatologists Should Know about Hughes Syndrome

    February 17, 2016

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

    Meet the HEP C Challenge

    December 1, 2008

    Keep a hepatitis C virus infection from hindering RA treatment

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences